Clinical Trials · NCT04061200
Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Steno Diabetes Center Copenhagen
- Enrollment
- 80
- Start date
- Nov 2019
- Locations
- 1 site, Denmark
- Primary endpoint
- Albuminuria